Drug and Gene Delivery System - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512240809

Publication Date:

December 11, 2024

Pages:

164

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Drug and Gene Delivery System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Drug and Gene Delivery System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drug and Gene Delivery System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Drug and Gene Delivery System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Drug and Gene Delivery System include Pfizer, Johnson & Johnson, Novartis, Roche, Merck & Co., Sanofi, GlaxoSmithKline, AbbVie and AstraZeneca, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug and Gene Delivery System, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug and Gene Delivery System by region & country, by Type, and by Application.
The Drug and Gene Delivery System market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug and Gene Delivery System.
麻豆原创 Segmentation
By Company
Pfizer
Johnson & Johnson
Novartis
Roche
Merck & Co.
Sanofi
GlaxoSmithKline
AbbVie
AstraZeneca
Bayer
Bristol-MyersSquibb
Celgene
Amgen
Biogen
Gilead Sciences
Illumina
Regeneron Pharmaceuticals
Vertex Pharmaceuticals
Moderna
CRISPR Therapeutics
Segment by Type:
Drug Delivery System
Gene Delivery System
Segment by Application
Diabetes
Central Nervous System
Infectious Disease
Oncology
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug and Gene Delivery System manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Drug and Gene Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Drug and Gene Delivery System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Drug and Gene Delivery System Product Introduction
1.2 Global Drug and Gene Delivery System 麻豆原创 Size Forecast
1.3 Drug and Gene Delivery System 麻豆原创 Trends & Drivers
1.3.1 Drug and Gene Delivery System Industry Trends
1.3.2 Drug and Gene Delivery System 麻豆原创 Drivers & Opportunity
1.3.3 Drug and Gene Delivery System 麻豆原创 Challenges
1.3.4 Drug and Gene Delivery System 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug and Gene Delivery System Players Revenue Ranking (2023)
2.2 Global Drug and Gene Delivery System Revenue by Company (2019-2024)
2.3 Key Companies Drug and Gene Delivery System Manufacturing Base Distribution and Headquarters
2.4 Key Companies Drug and Gene Delivery System Product Offered
2.5 Key Companies Time to Begin Mass Production of Drug and Gene Delivery System
2.6 Drug and Gene Delivery System 麻豆原创 Competitive Analysis
2.6.1 Drug and Gene Delivery System 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Drug and Gene Delivery System Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug and Gene Delivery System as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Drug Delivery System
3.1.2 Gene Delivery System
3.2 Global Drug and Gene Delivery System Sales Value by Type
3.2.1 Global Drug and Gene Delivery System Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drug and Gene Delivery System Sales Value, by Type (2019-2030)
3.2.3 Global Drug and Gene Delivery System Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diabetes
4.1.2 Central Nervous System
4.1.3 Infectious Disease
4.1.4 Oncology
4.1.5 Other
4.2 Global Drug and Gene Delivery System Sales Value by Application
4.2.1 Global Drug and Gene Delivery System Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drug and Gene Delivery System Sales Value, by Application (2019-2030)
4.2.3 Global Drug and Gene Delivery System Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Drug and Gene Delivery System Sales Value by Region
5.1.1 Global Drug and Gene Delivery System Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drug and Gene Delivery System Sales Value by Region (2019-2024)
5.1.3 Global Drug and Gene Delivery System Sales Value by Region (2025-2030)
5.1.4 Global Drug and Gene Delivery System Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Drug and Gene Delivery System Sales Value, 2019-2030
5.2.2 North America Drug and Gene Delivery System Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Drug and Gene Delivery System Sales Value, 2019-2030
5.3.2 Europe Drug and Gene Delivery System Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Drug and Gene Delivery System Sales Value, 2019-2030
5.4.2 Asia Pacific Drug and Gene Delivery System Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Drug and Gene Delivery System Sales Value, 2019-2030
5.5.2 South America Drug and Gene Delivery System Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Drug and Gene Delivery System Sales Value, 2019-2030
5.6.2 Middle East & Africa Drug and Gene Delivery System Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drug and Gene Delivery System Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drug and Gene Delivery System Sales Value
6.3 United States
6.3.1 United States Drug and Gene Delivery System Sales Value, 2019-2030
6.3.2 United States Drug and Gene Delivery System Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drug and Gene Delivery System Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug and Gene Delivery System Sales Value, 2019-2030
6.4.2 Europe Drug and Gene Delivery System Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drug and Gene Delivery System Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drug and Gene Delivery System Sales Value, 2019-2030
6.5.2 China Drug and Gene Delivery System Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drug and Gene Delivery System Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drug and Gene Delivery System Sales Value, 2019-2030
6.6.2 Japan Drug and Gene Delivery System Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drug and Gene Delivery System Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drug and Gene Delivery System Sales Value, 2019-2030
6.7.2 South Korea Drug and Gene Delivery System Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drug and Gene Delivery System Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drug and Gene Delivery System Sales Value, 2019-2030
6.8.2 Southeast Asia Drug and Gene Delivery System Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drug and Gene Delivery System Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drug and Gene Delivery System Sales Value, 2019-2030
6.9.2 India Drug and Gene Delivery System Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drug and Gene Delivery System Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer Drug and Gene Delivery System Products, Services and Solutions
7.1.4 Pfizer Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Profile
7.2.2 Johnson & Johnson Main Business
7.2.3 Johnson & Johnson Drug and Gene Delivery System Products, Services and Solutions
7.2.4 Johnson & Johnson Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.2.5 Johnson & Johnson Recent Developments
7.3 Novartis
7.3.1 Novartis Profile
7.3.2 Novartis Main Business
7.3.3 Novartis Drug and Gene Delivery System Products, Services and Solutions
7.3.4 Novartis Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.3.5 Roche Recent Developments
7.4 Roche
7.4.1 Roche Profile
7.4.2 Roche Main Business
7.4.3 Roche Drug and Gene Delivery System Products, Services and Solutions
7.4.4 Roche Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.4.5 Roche Recent Developments
7.5 Merck & Co.
7.5.1 Merck & Co. Profile
7.5.2 Merck & Co. Main Business
7.5.3 Merck & Co. Drug and Gene Delivery System Products, Services and Solutions
7.5.4 Merck & Co. Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.5.5 Merck & Co. Recent Developments
7.6 Sanofi
7.6.1 Sanofi Profile
7.6.2 Sanofi Main Business
7.6.3 Sanofi Drug and Gene Delivery System Products, Services and Solutions
7.6.4 Sanofi Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.6.5 Sanofi Recent Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Profile
7.7.2 GlaxoSmithKline Main Business
7.7.3 GlaxoSmithKline Drug and Gene Delivery System Products, Services and Solutions
7.7.4 GlaxoSmithKline Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.7.5 GlaxoSmithKline Recent Developments
7.8 AbbVie
7.8.1 AbbVie Profile
7.8.2 AbbVie Main Business
7.8.3 AbbVie Drug and Gene Delivery System Products, Services and Solutions
7.8.4 AbbVie Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.8.5 AbbVie Recent Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Profile
7.9.2 AstraZeneca Main Business
7.9.3 AstraZeneca Drug and Gene Delivery System Products, Services and Solutions
7.9.4 AstraZeneca Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.9.5 AstraZeneca Recent Developments
7.10 Bayer
7.10.1 Bayer Profile
7.10.2 Bayer Main Business
7.10.3 Bayer Drug and Gene Delivery System Products, Services and Solutions
7.10.4 Bayer Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.10.5 Bayer Recent Developments
7.11 Bristol-MyersSquibb
7.11.1 Bristol-MyersSquibb Profile
7.11.2 Bristol-MyersSquibb Main Business
7.11.3 Bristol-MyersSquibb Drug and Gene Delivery System Products, Services and Solutions
7.11.4 Bristol-MyersSquibb Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.11.5 Bristol-MyersSquibb Recent Developments
7.12 Celgene
7.12.1 Celgene Profile
7.12.2 Celgene Main Business
7.12.3 Celgene Drug and Gene Delivery System Products, Services and Solutions
7.12.4 Celgene Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.12.5 Celgene Recent Developments
7.13 Amgen
7.13.1 Amgen Profile
7.13.2 Amgen Main Business
7.13.3 Amgen Drug and Gene Delivery System Products, Services and Solutions
7.13.4 Amgen Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.13.5 Amgen Recent Developments
7.14 Biogen
7.14.1 Biogen Profile
7.14.2 Biogen Main Business
7.14.3 Biogen Drug and Gene Delivery System Products, Services and Solutions
7.14.4 Biogen Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.14.5 Biogen Recent Developments
7.15 Gilead Sciences
7.15.1 Gilead Sciences Profile
7.15.2 Gilead Sciences Main Business
7.15.3 Gilead Sciences Drug and Gene Delivery System Products, Services and Solutions
7.15.4 Gilead Sciences Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.15.5 Gilead Sciences Recent Developments
7.16 Illumina
7.16.1 Illumina Profile
7.16.2 Illumina Main Business
7.16.3 Illumina Drug and Gene Delivery System Products, Services and Solutions
7.16.4 Illumina Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.16.5 Illumina Recent Developments
7.17 Regeneron Pharmaceuticals
7.17.1 Regeneron Pharmaceuticals Profile
7.17.2 Regeneron Pharmaceuticals Main Business
7.17.3 Regeneron Pharmaceuticals Drug and Gene Delivery System Products, Services and Solutions
7.17.4 Regeneron Pharmaceuticals Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.17.5 Regeneron Pharmaceuticals Recent Developments
7.18 Vertex Pharmaceuticals
7.18.1 Vertex Pharmaceuticals Profile
7.18.2 Vertex Pharmaceuticals Main Business
7.18.3 Vertex Pharmaceuticals Drug and Gene Delivery System Products, Services and Solutions
7.18.4 Vertex Pharmaceuticals Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.18.5 Vertex Pharmaceuticals Recent Developments
7.19 Moderna
7.19.1 Moderna Profile
7.19.2 Moderna Main Business
7.19.3 Moderna Drug and Gene Delivery System Products, Services and Solutions
7.19.4 Moderna Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.19.5 Moderna Recent Developments
7.20 CRISPR Therapeutics
7.20.1 CRISPR Therapeutics Profile
7.20.2 CRISPR Therapeutics Main Business
7.20.3 CRISPR Therapeutics Drug and Gene Delivery System Products, Services and Solutions
7.20.4 CRISPR Therapeutics Drug and Gene Delivery System Revenue (US$ Million) & (2019-2024)
7.20.5 CRISPR Therapeutics Recent Developments
8 Industry Chain Analysis
8.1 Drug and Gene Delivery System Industrial Chain
8.2 Drug and Gene Delivery System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drug and Gene Delivery System Sales Model
8.5.2 Sales Channel
8.5.3 Drug and Gene Delivery System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Pfizer
Johnson & Johnson
Novartis
Roche
Merck & Co.
Sanofi
GlaxoSmithKline
AbbVie
AstraZeneca
Bayer
Bristol-MyersSquibb
Celgene
Amgen
Biogen
Gilead Sciences
Illumina
Regeneron Pharmaceuticals
Vertex Pharmaceuticals
Moderna
CRISPR Therapeutics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.